WallStSmart
LGVN

Longeveron LLC

NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY

$0.85
-1.74% today

Updated 2026-04-30

Market cap
$26.35M
P/E ratio
—
P/S ratio
21.98x
EPS (TTM)
$-1.29
Dividend yield
—
52W range
$0 – $2
Volume
6.9M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Longeveron LLC (LGVN) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20182019202020212022202320242025
Revenue$2.13M$5.63M$5.63M$1.31M$1.22M$709000.00$2.39M$1.20M
Revenue growth (YoY)—+163.7%-0.0%-76.8%-6.4%-42.0%+237.4%-49.9%
Cost of revenue$1.45M$3.80M$3.80M$716000.00$725000.00$488000.00$508000.00$396000.00
Gross profit$680649.00$1.83M$1.83M$590000.00$497000.00$221000.00$1.88M$803000.00
Gross margin31.9%32.4%32.4%45.2%40.7%31.2%78.8%67.0%
R&D$3.88M$2.67M$2.67M$7.09M$9.37M$9.07M$8.14M$12.04M
SG&A$3.12M$2.73M$2.73M$9.74M$8.12M$12.18M$9.47M$12.05M
Operating income$-6.36M$-3.78M$-3.78M$-17.46M$-18.04M$-21.03M$-16.52M$-23.29M
Operating margin-298.0%-67.1%-67.1%-1336.6%-1476.5%-2966.0%-690.7%-1942.2%
EBITDA$-5.59M$-2.95M$-2.93M$-16.13M$-17.15M$-20.08M$-15.56M$-22.06M
EBITDA margin-261.9%-52.3%-52.0%-1234.8%-1403.4%-2832.6%-650.7%-1839.9%
EBIT$-6.34M$-3.71M$-3.71M$-17.04M$-18.04M$-21.03M$-16.52M$-23.29M
Interest expense$0.00$169.00$6541.00$4000.00$287000.00———
Income tax————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-6.34M$-3.72M$-3.72M$-17.05M$-18.84M$-21.41M$-15.97M$-22.70M
Net income growth (YoY)—+41.3%-0.0%-358.1%-10.5%-13.7%+25.4%-42.1%
Profit margin-296.8%-66.1%-66.1%-1305.1%-1541.3%-3020.2%-667.8%-1893.6%